These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2447321)

  • 1. [Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders].
    Wierzchowiecki M; Swiderczuk A; Dyderski S; Masiakowski J; Jazienicki B
    Kardiol Pol; 1987; 30(9):577-82. PubMed ID: 2447321
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of biological availability and anti-arrhythmic effect of a new drug Phenytoinum "Polfa"].
    Wierzchowiecki M; Masiakowski J; Michalski M; Juszczak A; Dyderski S
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):476-8. PubMed ID: 1703655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the bioavailability of Polfa phenytoin tablets].
    Lazowski J; Lypka A; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1978; 12(3):251-5. PubMed ID: 683430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of biological availability and anti-arrhythmia effectiveness of Mexicard (mexiletine Polfa)].
    Sadowski Z; Paczkowski D; Markiewicz M; Nartowicz E; Koliński P; Filipek M
    Kardiol Pol; 1989; 32(5):266-72. PubMed ID: 2483958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a high-fat meal on the bioavailability of phenytoin in a commercial powder with a large particle size.
    Hamaguchi T; Shinkuma D; Irie T; Yamanaka Y; Morita Y; Iwamoto B; Miyoshi K; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):326-30. PubMed ID: 8370631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of various anti-arrhythmia drugs on serum digoxin level].
    Halawa B; Mazurek W
    Wiad Lek; 1981 Apr; 34(7):537-40. PubMed ID: 6168119
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma phenytoin levels produced by various phenytoin preparations.
    Sansom LN; O'Reilly WJ; Wiseman CW; Stern LM; Derham J
    Med J Aust; 1975 Oct; 2(15):593-5. PubMed ID: 1105111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and therapy of cardiac rhythm disorders. Experiences with a diphenylhydantoin-meprobamate preparation (Cusitan)].
    Gebauer D
    Munch Med Wochenschr; 1971 Mar; 113(12):436-40. PubMed ID: 4101391
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diphenylhydantoin therapy in heart rhythm disorders].
    Delius W
    Med Klin; 1966 Nov; 61(46):1836-8. PubMed ID: 4172430
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy and risks of diphenylhydantoin in cardiac arrhythmias].
    Reimann R; Lemmel W; Theisen K
    Munch Med Wochenschr; 1971 Jun; 113(23):893-9. PubMed ID: 4103259
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative bioavailability of 2 oral solid phenytoin dosage forms.
    Naik D; Morton DJ
    Cent Afr J Med; 1989 Apr; 35(4):384-8. PubMed ID: 2605620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the emulsion sign in phenytoin bioavailability.
    Savio EO; Fagiolino P; Jelen M; León AS
    Boll Chim Farm; 1994 Apr; 133(4):239-45. PubMed ID: 8068235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study.
    Rojanasthien N; Chaichana N; Teekachunhatean S; Kumsorn B; Sangdee C; Chankrachang S
    J Med Assoc Thai; 2007 Sep; 90(9):1883-93. PubMed ID: 17957935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of phenytoin availability from pharmaceutical preparations].
    Leucuţa SE; Almaşu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):273-82. PubMed ID: 2951832
    [No Abstract]   [Full Text] [Related]  

  • 15. Particle size dependency of dissolution rate and human bioavailability of phenytoin in powders and phenytoin-polyethylene glycol solid dispersions.
    Yakou S; Umehara K; Sonobe T; Nagai T; Sugihara M; Fukuyama Y
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4130-6. PubMed ID: 6529807
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of routine monitoring data for determination of the population pharmacokinetics and enteral bioavailability of phenytoin in neonates and infants with seizures.
    Al Za'abi M; Lanner A; Xiaonian X; Donovan T; Charles B
    Ther Drug Monit; 2006 Dec; 28(6):793-9. PubMed ID: 17164696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interaction of phenytoin with propranolol, procainamide and digoxin].
    Halawa B
    Pol Tyg Lek; 1985 Jul; 40(28):790-3. PubMed ID: 4059101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of diphenylhydantoin on auriculoventricular and intraventricular conduction in humans].
    Benaim R; Chapelle M; Chiche P
    Ann Cardiol Angeiol (Paris); 1972; 21(4):379-88. PubMed ID: 4119867
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of premature cardiac contractions.
    McGuire J
    Mod Treat; 1970 Jan; 7(1):31-9. PubMed ID: 4194311
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy monitored by the measurement of phenytoin levels in patients with ventricular disorders of cardiac rhythm].
    Wierzchowiecki M; Masiakowski J; Dyderski S; Cieszyński T; Jankowiak M
    Kardiol Pol; 1987; 30(9):583-8. PubMed ID: 3695063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.